Article PDF
References
Grainger, D.J., Witchell, C.M. & Metcalfe, J.C. Tamoxifen elevates transforming growth factor-β and suppressed diet-induced formation of lipid lesions in mouse aorta. Nature Med. 1, 1067–1073 (1995).
Wiseman, H., New membrane mediated mechanisms of action and therapeitoc advances. Trends Pharmacol. Sci. 15, 83–89 (1994).
Wilseman, H., Paganga, G., Rice-Evans, C. & Halliwell, B. Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: A Mechanism accounting for the cordioprotective action of tamoxifen? Biochem. J. 292, 635–638. (1993).
Grainger, D.J. et al. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein (a) mice. Nature 370, 460–462 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grainger, D. Reply to “Talking tamoxifen to heart”. Nat Med 1, 1226 (1995). https://doi.org/10.1038/nm1295-1226c
Issue Date:
DOI: https://doi.org/10.1038/nm1295-1226c